Board Meeting

ALKEM LABORATORIES LTD.

NSE : ALKEMBSE : 539523ISIN CODE : INE540L01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE4976.75-22.25 (-0.45 %)
PREV CLOSE ( ) 4999.00
OPEN PRICE ( ) 4889.60
BID PRICE (QTY) 4977.85 (10)
OFFER PRICE (QTY) 4984.30 (32)
VOLUME 9444
TODAY'S LOW / HIGH ( )4849.30 4991.30
52 WK LOW / HIGH ( )3204 5519.1
NSE4980.00-24.2 (-0.48 %)
PREV CLOSE( ) 5004.20
OPEN PRICE ( ) 4935.00
BID PRICE (QTY) 4980.10 (1)
OFFER PRICE (QTY) 4982.00 (9)
VOLUME 270776
TODAY'S LOW / HIGH( ) 4820.05 4994.35
52 WK LOW / HIGH ( )3186.3 5520

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.